Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Clinical trial NCT02658357 · COMPLETED
Trial details
- NCT number
- NCT02658357
- Sponsor
- Braeburn Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-08-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.